Learn about the ABILIFY MYCITE® System - 2

Gain insights into your patients' lives
between visits
Knowing how often your patients are taking their
medication may help change how you treat them
When equipped with the data delivered by the ABILIFY MYCITE®
This is Erin. Ten years ago,
she was diagnosed with
major depressive disorder.
After her initial diagnosis,
her doctor prescribed an
antidepressant. Following
her most recent hospitalization
for her depressive symptoms,
her nurse practitioner added
oral aripiprazole to her
treatment regimen.
Erin is married and has 3
children. She loves spending
time with her family and
gardening. Recently, she has
been having trouble fulfilling
daily family responsibilities
and experiencing decreased
interest in her favorite hobby,
gardening.1,2
She admits
Erin: Hypothetical Patient.
having trouble taking her
antidepressant medication as
often as her doctor prescribed.
A dashboard
A dashboard
If you have a patient like Erin, you may only see her once a month. What kind
of information might give you a more complete picture about a patient like her?
Discover how the ABILIFY MYCITE®
System can provide data-driven insights to
help inform treatment decisions for patients like Erin.
A dashboard
A dashboard
An app
An app
An app
An app
System, a patient like Erin,
her nurse practitioner, care team, and support network can have more open conversations
about her mental health and treatment plan.
The ABILIFY MYCITE System is intended to track
drug ingestion over time
The 5 components of the system
ApillApill
Apill
A pill
A conversation
A conversation
A conversation
A conversation
A patch
ApatchApatch
Apatch
The ABILIFY MYCITE System
is made up of 5 components:
a pill, a patch, an app, a
dash board, and a conversation.
Together, the system records
medication ingestion and
other daily data. This gives
a patient and their healthcare
provider, care team, and
support network a more
complete picture of how the
patient is doing between visits
(ie, activity, time spent resting,
mood, rest quality, and
reason for a missed dose).
Contraindication: Known hypersensitivity reaction to aripiprazole. Reactions have
ranged from pruritus/urticaria to anaphylaxis.
The impact of the ABILIFY MYCITE System on treatment adherence has not been demonstrated.
Some factors, such as connectivity, transmitter malfunction, or device availability, may impact the
consistency and reliability of data detection, collection and transmission. Only functions related to
tracking drug ingestion have been evaluated or approved by FDA.
2
Please read IMPORTANT SAFETY INFORMATION on pages 5-6.

Learn about the ABILIFY MYCITE® System

Table of Contents for the Digital Edition of Learn about the ABILIFY MYCITE® System

Learn about the ABILIFY MYCITE® System - 1
Learn about the ABILIFY MYCITE® System - 2
Learn about the ABILIFY MYCITE® System - 3
Learn about the ABILIFY MYCITE® System - 4
Learn about the ABILIFY MYCITE® System - 5
Learn about the ABILIFY MYCITE® System - 6
Learn about the ABILIFY MYCITE® System - 7
https://www.nxtbookmedia.com